Shandong Sanyuan Biotechnology Co.Ltd. Total Assets
Shandong Sanyuan Biotechnology Co.Ltd. total assets. Based on the latest financial reports, Shandong Sanyuan Biotechnology Co.Ltd. (301206) holds total assets worth CN¥4.48 Billion CNY (≈ $655.85 Million USD) as of September 2025. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. Also see cash efficiency ratio of Shandong Sanyuan Biotechnology Co.Ltd. for how efficiently the company converts equity into cash flow.
Total Assets of Shandong Sanyuan Biotechnology Co.Ltd. (2013–2024)
Total assets of Shandong Sanyuan Biotechnology Co.Ltd. from 2013 to 2024. This chart illustrates how Shandong Sanyuan Biotechnology Co.Ltd.'s total assets have evolved over time, based on quarterly financial data. See current stock price of Shandong Sanyuan Biotechnology Co.Ltd. for real-time trading data and today's change.
Shandong Sanyuan Biotechnology Co.Ltd. - Asset Composition Analysis
Shandong Sanyuan Biotechnology Co.Ltd. Total Assets Breakdown (December 2024)
Shandong Sanyuan Biotechnology Co.Ltd. total assets breakdown as of December 2024. Shandong Sanyuan Biotechnology Co.Ltd.'s total assets of CN¥4.48 Billion consist of 70.5% current assets and 29.5% non-current assets. Explore Shandong Sanyuan Biotechnology Co.Ltd. current assets vs equity to assess how much short-term liquidity the company maintains relative to its equity base.
| Asset Category | Amount (CNY) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | CN¥0.00 | 3.3% |
| Accounts Receivable | CN¥131.07 Million | 2.7% |
| Inventory | CN¥142.71 Million | 3.0% |
| Property, Plant & Equipment | CN¥0.00 | 0.0% |
| Intangible Assets | CN¥46.43 Million | 1.0% |
| Goodwill | CN¥0.00 | 0.0% |
Asset Composition Trend (2013–2024)
This chart illustrates how Shandong Sanyuan Biotechnology Co.Ltd.'s asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Shandong Sanyuan Biotechnology Co.Ltd.'s current assets represent 70.5% of total assets in 2024, an increase from 61.2% in 2013.
- Cash Position: Cash and equivalents constituted 3.3% of total assets in 2024, down from 5.7% in 2013.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 0.0% of total assets, a decrease from 2.0% in 2013.
- Asset Diversification: The largest asset category is inventory at 3.0% of total assets.
Shandong Sanyuan Biotechnology Co.Ltd. Competitors by Total Assets
Key competitors of Shandong Sanyuan Biotechnology Co.Ltd. based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Compagnie du Bois Sauvage SA
BR:COMB
|
Belgium | €708.54 Million |
|
WAWEL SA
WAR:WWL
|
Poland | zł857.90 Million |
|
Vishwaraj Sugar Industries Limited
NSE:VISHWARAJ
|
India | Rs8.28 Billion |
|
FFI Holdings Ltd
AU:FFI
|
Australia | AU$80.35 Million |
|
Yowie Group Ltd
AU:YOW
|
Australia | AU$17.52 Million |
|
Josef Manner & Comp. AG
VI:MAN
|
Austria | €166.37 Million |
|
Newtree S.A
BR:NEWT
|
Belgium | €1.21 Million |
|
Jalles Machado S/A
SA:JALL3
|
Brazil | R$7.42 Billion |
Shandong Sanyuan Biotechnology Co.Ltd. - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 21.08 | 17.90 | 1.46 |
| Quick Ratio | 19.76 | 17.27 | 1.20 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | CN¥2.16 Billion | CN¥3.17 Billion | CN¥119.78 Million |
Shandong Sanyuan Biotechnology Co.Ltd. - Advanced Valuation Insights
This section examines the relationship between Shandong Sanyuan Biotechnology Co.Ltd.'s asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 1.25 |
| Latest Market Cap to Assets Ratio | 0.15 |
| Asset Growth Rate (YoY) | -0.1% |
| Total Assets | CN¥4.81 Billion |
| Market Capitalization | $699.31 Million USD |
Valuation Analysis
Below Book Valuation: The market values Shandong Sanyuan Biotechnology Co.Ltd.'s assets below their book value (0.15x), which may indicate investor concerns about asset quality or future growth.
Slight Asset Contraction: Shandong Sanyuan Biotechnology Co.Ltd.'s assets decreased by 0.1% over the past year, which may reflect streamlining or optimization of resources.
Annual Total Assets for Shandong Sanyuan Biotechnology Co.Ltd. (2013–2024)
The table below shows the annual total assets of Shandong Sanyuan Biotechnology Co.Ltd. from 2013 to 2024.
| Year | Total Assets | Change |
|---|---|---|
| 2024-12-31 | CN¥4.81 Billion ≈ $703.16 Million |
-0.11% |
| 2023-12-31 | CN¥4.81 Billion ≈ $703.92 Million |
-1.22% |
| 2022-12-31 | CN¥4.87 Billion ≈ $712.62 Million |
+198.01% |
| 2021-12-31 | CN¥1.63 Billion ≈ $239.13 Million |
+109.13% |
| 2020-12-31 | CN¥781.39 Million ≈ $114.34 Million |
+49.19% |
| 2019-12-31 | CN¥523.74 Million ≈ $76.64 Million |
+87.30% |
| 2018-12-31 | CN¥279.63 Million ≈ $40.92 Million |
+54.39% |
| 2017-12-31 | CN¥181.12 Million ≈ $26.50 Million |
+42.52% |
| 2016-12-31 | CN¥127.08 Million ≈ $18.60 Million |
+89.82% |
| 2015-12-31 | CN¥66.95 Million ≈ $9.80 Million |
+16.89% |
| 2014-12-31 | CN¥57.27 Million ≈ $8.38 Million |
+26.77% |
| 2013-12-31 | CN¥45.18 Million ≈ $6.61 Million |
-- |
About Shandong Sanyuan Biotechnology Co.Ltd.
Shandong Sanyuan Biotechnology Co.,Ltd. engages in the research and development, production, and sale of erythritol and compound sugar products in China. Its products are used in table sugar, flavored sugar, and beverages; candy and chocolate food; baked food; health food; medical supplies; cosmetic products; chemical products; and other applications. The company exports its products to Europe, t… Read more